About HRA Pharma Rare Diseases
HRA Pharma Rare Diseases was established in 1996 in Chatillon, France, within the pharmaceutical sector. Operations center on treatments for rare and ultra-rare diseases, with a portfolio that includes products such as Metopirone, Ketoconazole HRA, and Lysodren. Healthcare solutions are provided to support patients affected by these conditions. The company is led by CEO David Wright, focusing on specialized therapeutic areas.
- Headquarter Chatillon, France
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Esteve
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of HRA Pharma Rare Diseases
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in HRA Pharma Rare Diseases
HRA Pharma Rare Diseases has secured backing from 1 investor. Prominent investors backing the company include Esteve. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Therapies for chronic pain treatment are developed by Esteve.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by HRA Pharma Rare Diseases
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - HRA Pharma Rare Diseases
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Hra Pharma Rare Diseases Comparisons
Competitors of HRA Pharma Rare Diseases
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about HRA Pharma Rare Diseases
When was HRA Pharma Rare Diseases founded?
HRA Pharma Rare Diseases was founded in 1996.
Where is HRA Pharma Rare Diseases located?
HRA Pharma Rare Diseases is headquartered in Chatillon, France. It is registered at Chatillon, Ile-de-france, France.
Who is the current CEO of HRA Pharma Rare Diseases?
David Wright is the current CEO of HRA Pharma Rare Diseases.
What does HRA Pharma Rare Diseases do?
HRA Pharma Rare Diseases was established in 1996 in Chatillon, France, within the pharmaceutical sector. Operations center on treatments for rare and ultra-rare diseases, with a portfolio that includes products such as Metopirone, Ketoconazole HRA, and Lysodren. Healthcare solutions are provided to support patients affected by these conditions. The company is led by CEO David Wright, focusing on specialized therapeutic areas.
Who are HRA Pharma Rare Diseases's investors?
HRA Pharma Rare Diseases has 1 investor. Key investors include Esteve.